ArticleHepatology communications2018

NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Marlyn J Mayo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.